Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Gains from Investment Securities: 2020-2024

Historic Gains from Investment Securities for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $8,460.

  • iSpecimen's Gains from Investment Securities was N/A to $73,084 in Q3 2025 from the same period last year, while for Sep 2025 it was $73,084, marking a year-over-year change of. This contributed to the annual value of $8,460 for FY2024, which is 42.89% down from last year.
  • Per iSpecimen's latest filing, its Gains from Investment Securities stood at $8,460 for FY2024, which was down 42.89% from $14,813 recorded in FY2023.
  • iSpecimen's Gains from Investment Securities' 5-year high stood at $329,246 during FY2021, with a 5-year trough of $8,460 in FY2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was $14,813 (2023), whereas its average is $106,944.
  • As far as peak fluctuations go, iSpecimen's Gains from Investment Securities soared by 30.73% in 2021, and later slumped by 95.02% in 2023.
  • Yearly analysis of 5 years shows iSpecimen's Gains from Investment Securities stood at $251,847 in 2020, then spiked by 30.73% to $329,246 in 2021, then fell by 9.62% to $297,559 in 2022, then tumbled by 95.02% to $14,813 in 2023, then plummeted by 42.89% to $8,460 in 2024.